Consolidated Statements of Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Total	Common Stock	Additional Pain In Capital	Accumulated Deficit
Balance at Dec. 31, 2022	$ 292,338	$ 4	$ 530,448	$ (238,114)
Balance, shares at Dec. 31, 2022		42,954,820
Issuance of common stock upon exercise of stock options	3		3
Issuance of common stock upon exercise of stock options, shares		713
Issuance of common stock upon vesting of restricted stock, shares		3,205
Shares withheld for taxes	(10)		(10)
Shares withheld for taxes, shares		(1,307)
Stock-based compensation expense	4,765		4,765
Net Income (Loss)	(30,881)			(30,881)
Balance at Mar. 31, 2023	266,215	$ 4	535,206	(268,995)
Balance, shares at Mar. 31, 2023		42,957,431
Balance at Dec. 31, 2023	170,175	$ 4	550,943	(380,772)
Balance, shares at Dec. 31, 2023		43,270,386
Issuance of common stock upon exercise of stock options	$ 189		189
Issuance of common stock upon exercise of stock options, shares	88,283	88,283
Issuance of common stock upon vesting of restricted stock, shares		148,980
Shares withheld for taxes	$ (141)		(141)
Shares withheld for taxes, shares		(67,813)
Issuance of common stock pursuant to at-the-market offering, net of issuance costs of $0.6 million, Amount	19,266	$ 1	19,265
Issuance of common stock pursuant to at-the-market offering, net of issuance costs of $0.6 million, Share		6,350,000
Issuance of common stock and pre-funded warrants pursuant to underwritten public offering, net of issuance costs of $6.3 million, Amount	91,652	$ 3	91,649
Issuance of common stock and pre-funded warrants pursuant to underwritten public offering, net of issuance costs of $6.3 million, Share		32,379,667
Stock-based compensation expense	5,679		5,679
Net Income (Loss)	(28,016)			(28,016)
Balance at Mar. 31, 2024	$ 258,804	$ 8	$ 667,584	$ (408,788)
Balance, shares at Mar. 31, 2024		82,169,503